Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dale

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
Clinical Pharmacology and Therapeutics|September 28, 2021
TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical ResultsAlyson L Dickson, Laura L Daniel, Jacy Zanussi, et al.
Cancer Research|May 26, 2011
A multistage association study identifies a breast cancer genetic locus at NCOA7Kathryn S P Higginbotham, Joan P Breyer, Kevin M Bradley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2012
A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24Kathryn S Higginbotham, Joan P Breyer, Kate M McReynolds, et al.
Annals of Internal Medicine|June 20, 2022
Race, Genotype, and Azathioprine Discontinuation : A Cohort StudyAlyson L Dickson, Laura L Daniel, Elise Jackson, et al.
Clinical and Translational Science|February 4, 2022
Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicityLaura L Daniel, Alyson L Dickson, Jacy T Zanussi, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2022
Synthesis and SAR of novel GPR39 agonists and positive allosteric modulatorsRussell Burley, Richard C Hewer, Martin Teall, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 1, 2022
Age differences in the functional architecture of the human brainRoni Setton, Laetitia Mwilambwe-Tshilobo, Manesh Girn, et al.
American Journal of Clinical Pathology|October 15, 2013
Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approachAdam C Seegmiller, Annette S Kim, Claudio A Mosse, et al.
The American Journal of Surgical Pathology|December 25, 2024
DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell CarcinomaStephanie A Hart, Jen-Fan Hang, Rebecca D Chernock, et al.
Journal of Clinical Microbiology|May 8, 2003
Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international studyIngrid Filliol, Jeffrey R Driscoll, Dick van Soolingen, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Clinical Pharmacology and Therapeutics|September 28, 2021
TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical ResultsAlyson L Dickson, Laura L Daniel, Jacy Zanussi, et al.
Cancer Research|May 26, 2011
A multistage association study identifies a breast cancer genetic locus at NCOA7Kathryn S P Higginbotham, Joan P Breyer, Kevin M Bradley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2012
A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24Kathryn S Higginbotham, Joan P Breyer, Kate M McReynolds, et al.
Annals of Internal Medicine|June 20, 2022
Race, Genotype, and Azathioprine Discontinuation : A Cohort StudyAlyson L Dickson, Laura L Daniel, Elise Jackson, et al.
Clinical and Translational Science|February 4, 2022
Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicityLaura L Daniel, Alyson L Dickson, Jacy T Zanussi, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2022
Synthesis and SAR of novel GPR39 agonists and positive allosteric modulatorsRussell Burley, Richard C Hewer, Martin Teall, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 1, 2022
Age differences in the functional architecture of the human brainRoni Setton, Laetitia Mwilambwe-Tshilobo, Manesh Girn, et al.
American Journal of Clinical Pathology|October 15, 2013
Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approachAdam C Seegmiller, Annette S Kim, Claudio A Mosse, et al.
The American Journal of Surgical Pathology|December 25, 2024
DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell CarcinomaStephanie A Hart, Jen-Fan Hang, Rebecca D Chernock, et al.
Journal of Clinical Microbiology|May 8, 2003
Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international studyIngrid Filliol, Jeffrey R Driscoll, Dick van Soolingen, et al.
Pageof 25